{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:23:10Z","timestamp":1787772190637,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Application for Policy Guidance Projects of Yantai Science and Technology Innovation Development Plan in 2023","award":["2023YD012"],"award-info":[{"award-number":["2023YD012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00210-025-04040-y","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:17:59Z","timestamp":1742278679000},"page":"12133-12146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Overexpression of KIF2C amplifies tamoxifen resistance and lung metastasis of breast cancer through PLK1\/C-Myc pathway"],"prefix":"10.1007","volume":"398","author":[{"given":"Rui","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"4040_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/elps.202100217","volume":"43","author":"AA Alhusban","year":"2022","unstructured":"Alhusban AA, Hamadneh LA, Albustanji S, Shallan AI (2022) Lactate and pyruvate levels correlation with lactate dehydrogenase gene expression and glucose consumption in Tamoxifen-resistant MCF-7 cells using capillary electrophoresis with contactless conductivity detection (CE-C(4) D). Electrophoresis 43:446\u2013455. https:\/\/doi.org\/10.1002\/elps.202100217","journal-title":"Electrophoresis"},{"key":"4040_CR2","doi-asserted-by":"publisher","first-page":"1434856","DOI":"10.1155\/2021\/1434856","volume":"2021","author":"L An","year":"2021","unstructured":"An L, Zhang J, Feng D, Zhao Y, Ouyang W, Shi R, Zhou X, Yu Z, Wei S, Min J, Wang H (2021) KIF2C Is a novel prognostic biomarker and correlated with immune infiltration in endometrial cancer. Stem Cells Int 2021:1434856. https:\/\/doi.org\/10.1155\/2021\/1434856","journal-title":"Stem Cells Int"},{"key":"4040_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12195-021-00694-9","volume":"15","author":"B Buyuk","year":"2022","unstructured":"Buyuk B, Jin S, Ye K (2022) Epithelial-to-mesenchymal transition signaling pathways responsible for breast cancer metastasis. Cell Mol Bioeng 15:1\u201313. https:\/\/doi.org\/10.1007\/s12195-021-00694-9","journal-title":"Cell Mol Bioeng"},{"key":"4040_CR4","doi-asserted-by":"publisher","unstructured":"Clusan L, Ferri\u00e8re F, Flouriot G and Pakdel F (2023) A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24076834","DOI":"10.3390\/ijms24076834"},{"key":"4040_CR5","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.mcp.2023.101938","volume":"72","author":"H Deng","year":"2023","unstructured":"Deng H, Gong X, Ji G, Li C, Cheng S (2023) KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2\/STAT3 signaling pathway. Mol Cell Probes 72:101938. https:\/\/doi.org\/10.1016\/j.mcp.2023.101938","journal-title":"Mol Cell Probes"},{"key":"4040_CR6","doi-asserted-by":"publisher","unstructured":"Fang L, Liu Q, Cui H, Zheng Y and Wu C (2022) Bioinformatics analysis highlight differentially expressed CCNB1 and PLK1 genes as potential anti-breast cancer drug targets and prognostic markers. Genes 13. https:\/\/doi.org\/10.3390\/genes13040654.","DOI":"10.3390\/genes13040654"},{"key":"4040_CR7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1200\/jco.22.01065","volume":"41","author":"PA Francis","year":"2023","unstructured":"Francis PA, Fleming GF, L\u00e1ng I, Ciruelos EM, Bonnefoi HR, Bellet M, Bernardo A, Climent MA, Martino S, Bermejo B, Burstein HJ, Davidson NE, Geyer CE Jr, Walley BA, Ingle JN, Coleman RE, M\u00fcller B, Le Du F, Loibl S, Winer EP, Ruepp B, Loi S, Colleoni M, Coates AS, Gelber RD, Goldhirsch A, Regan MM (2023) Adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from SOFT. J Clin Oncol 41:1370\u20131375. https:\/\/doi.org\/10.1200\/jco.22.01065","journal-title":"J Clin Oncol"},{"key":"4040_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/cbf.3420","volume":"37","author":"H Gan","year":"2019","unstructured":"Gan H, Lin L, Hu N, Yang Y, Gao Y, Pei Y, Chen K, Sun B (2019) KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR-325-3p. Cell Biochem Funct 37:424\u2013431. https:\/\/doi.org\/10.1002\/cbf.3420","journal-title":"Cell Biochem Funct"},{"key":"4040_CR9","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1038\/s41598-023-30073-5","volume":"13","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang W, Sun L, Yu H, Wang Y, Feng L, Yang H (2023) KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3\u03b2-\u03b2-catenin pathway. Sci Rep 13:7288. https:\/\/doi.org\/10.1038\/s41598-023-30073-5","journal-title":"Sci Rep"},{"key":"4040_CR10","doi-asserted-by":"publisher","unstructured":"Gutteridge R, Ndiaye M, Liu X, Ahmad N (2016) Plk1 inhibitors in cancer therapy: from laboratory to clinics. 15:1427\u201335 https:\/\/doi.org\/10.1158\/1535-7163.Mct-15-0897","DOI":"10.1158\/1535-7163.Mct-15-0897"},{"key":"4040_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11095-019-2746-9","volume":"37","author":"K Hussaarts","year":"2019","unstructured":"Hussaarts K, Berger FA, Binkhorst L, Oomen-de Hoop E, van Leeuwen RWF, van Alphen RJ, Mathijssen-van Stein D, de Groot NMS, Mathijssen RHJ, van Gelder T (2019) The risk of QTc-interval prolongation in breast cancer patients treated with tamoxifen in combination with serotonin reuptake inhibitors. Pharm Res 37:7. https:\/\/doi.org\/10.1007\/s11095-019-2746-9","journal-title":"Pharm Res"},{"key":"4040_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1158\/1535-7163.mct-17-0545","volume":"17","author":"SB Jeong","year":"2018","unstructured":"Jeong SB, Im JH, Yoon JH, Bui QT, Lim SC, Song JM, Shim Y, Yun J, Hong J, Kang KW (2018b) Essential role of polo-like kinase 1 (Plk1) oncogene in tumor growth and metastasis of tamoxifen-resistant breast cancer. Mol Cancer Ther 17:825\u2013837. https:\/\/doi.org\/10.1158\/1535-7163.mct-17-0545","journal-title":"Mol Cancer Ther"},{"key":"4040_CR13","doi-asserted-by":"publisher","unstructured":"Jeong S, Im J, Yoon J, Bui Q, Lim S, Song J, Shim Y, Yun J, Hong J, Kang K (2018a) Essential role of polo-like kinase 1 (Plk1) oncogene in tumor growth and metastasis of tamoxifen-resistant breast cancer. 17:825\u2013837. https:\/\/doi.org\/10.1158\/1535-7163.Mct-17-0545.","DOI":"10.1158\/1535-7163.Mct-17-0545"},{"key":"4040_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12935-021-02235-w","volume":"21","author":"CF Jiang","year":"2021","unstructured":"Jiang CF, Xie YX, Qian YC, Wang M, Liu LZ, Shu YQ, Bai XM, Jiang BH (2021) TBX15\/miR-152\/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination. Cancer Cell Int 21:542. https:\/\/doi.org\/10.1186\/s12935-021-02235-w","journal-title":"Cancer Cell Int"},{"key":"4040_CR15","doi-asserted-by":"publisher","unstructured":"Kaidi Y, Jian G, Mao L (2019) Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis. Onco Targets Ther 12. https:\/\/doi.org\/10.2147\/ott.S158619.","DOI":"10.2147\/ott.S158619"},{"key":"4040_CR16","doi-asserted-by":"publisher","unstructured":"Kaszak I, Witkowska-Pi\u0142aszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P (2020) Role of cadherins in cancer-a review. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21207624","DOI":"10.3390\/ijms21207624"},{"key":"4040_CR17","doi-asserted-by":"publisher","unstructured":"Kreis NN, Moon HH, Wordeman L, Louwen F, Solbach C, Yuan J, Ritter A (2024) KIF2C\/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker. Crit Rev Clin Lab Sci 1\u201331. https:\/\/doi.org\/10.1080\/10408363.2024.2309933","DOI":"10.1080\/10408363.2024.2309933"},{"key":"4040_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13045-018-0577-5","volume":"11","author":"B Liu","year":"2018","unstructured":"Liu B, Wang T, Wang H, Zhang L, Xu F, Fang R, Li L, Cai X, Wu Y, Zhang W, Ye L (2018) Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol 11:26. https:\/\/doi.org\/10.1186\/s13045-018-0577-5","journal-title":"J Hematol Oncol"},{"key":"4040_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12885-023-10788-4","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu S, Ye Z, Xue V, Sun Q, Li H, Lu D (2023a) KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer. BMC Cancer 23:307. https:\/\/doi.org\/10.1186\/s12885-023-10788-4","journal-title":"BMC Cancer"},{"key":"4040_CR20","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1091\/mbc.e07-02-0110","volume":"18","author":"A Manning","year":"2007","unstructured":"Manning A, Ganem N, Bakhoum S, Wagenbach M, Wordeman L, Compton D (2007) The kinesin-13 proteins Kif2a, Kif2b, and Kif2c\/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell 18:2970\u20132909. https:\/\/doi.org\/10.1091\/mbc.e07-02-0110","journal-title":"Mol Biol Cell"},{"key":"4040_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.25122\/jml-2022-0085","volume":"15","author":"M Mirzaei","year":"2022","unstructured":"Mirzaei M, Sheikholeslami SA, Jalili A, Bereimipour A, Sharbati S, Kaveh V, Salari S (2022) Investigating the molecular mechanisms of Tamoxifen on the EMT pathway among patients with breast cancer. J Med Life 15:835\u2013844. https:\/\/doi.org\/10.25122\/jml-2022-0085","journal-title":"J Med Life"},{"key":"4040_CR22","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na TY, Schecterson L, Mendonsa AM, Gumbiner BM (2020) The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA 117:5931\u20135937. https:\/\/doi.org\/10.1073\/pnas.1918167117","journal-title":"Proc Natl Acad Sci USA"},{"key":"4040_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10911-024-09566-0","volume":"29","author":"R Nicotra","year":"2024","unstructured":"Nicotra R, Lutz C, Messal HA, Jonkers J (2024) Rat models of hormone receptor-positive breast cancer. J Mammary Gland Biol Neoplasia 29:12. https:\/\/doi.org\/10.1007\/s10911-024-09566-0","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"4040_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biopha.2015.07.005","volume":"74","author":"BN Prashanth Kumar","year":"2015","unstructured":"Prashanth Kumar BN, Rajput S, Bharti R, Parida S, Mandal M (2015) BI2536\u2013a PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells. Biomed Pharmacother 74:124\u201332. https:\/\/doi.org\/10.1016\/j.biopha.2015.07.005","journal-title":"Biomed Pharmacother"},{"key":"4040_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"4040_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcancer.2020.12.004","volume":"82","author":"OA Sukocheva","year":"2022","unstructured":"Sukocheva OA, Lukina E, Friedemann M, Menschikowski M, Hagelgans A, Aliev G (2022) The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives. Semin Cancer Biol 82:35\u201359. https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.004","journal-title":"Semin Cancer Biol"},{"key":"4040_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4040_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41419-019-1318-6","volume":"10","author":"B Targa","year":"2019","unstructured":"Targa B, Klipfel L, Cantaloube I, Salameh J, Benoit B, Po\u00fcs C, Baillet A (2019) Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel. Cell Death Dis 10:54. https:\/\/doi.org\/10.1038\/s41419-019-1318-6","journal-title":"Cell Death Dis"},{"key":"4040_CR29","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00109.2021","volume":"321","author":"KM Turner","year":"2021","unstructured":"Turner KM, Yeo SK, Holm TM, Shaughnessy E, Guan JL (2021) Heterogeneity within molecular subtypes of breast cancer. Am J Physiol Cell Physiol 321:C343-c354. https:\/\/doi.org\/10.1152\/ajpcell.00109.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"4040_CR30","doi-asserted-by":"publisher","unstructured":"Wei S, Lu C, Mo S, Huang H, Chen M, Li S, Kong L, Zhang H, Hoa P, Han C, Luo X (2024) Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K\/AKT\/MAPK signaling pathway. 35:237\u2013250. https:\/\/doi.org\/10.1097\/cad.0000000000001563","DOI":"10.1097\/cad.0000000000001563"},{"key":"4040_CR31","doi-asserted-by":"publisher","first-page":"27990","DOI":"10.18632\/oncotarget.15856","volume":"8","author":"Q Wu","year":"2017","unstructured":"Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q, Wei W, Zhang Y, Sun S (2017) Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget 8:27990\u201327996. https:\/\/doi.org\/10.18632\/oncotarget.15856","journal-title":"Oncotarget"},{"key":"4040_CR32","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.7150\/ijbs.55453","volume":"17","author":"DP Wu","year":"2021","unstructured":"Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX (2021) Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src\/PI3K\/Akt pathway. Int J Biol Sci 17:2380\u20132398. https:\/\/doi.org\/10.7150\/ijbs.55453","journal-title":"Int J Biol Sci"},{"key":"4040_CR33","doi-asserted-by":"publisher","unstructured":"Xinyu L, Yu L, Weibing L, Renzheng Y, Xiongfeng Z, Chaoqun X, Na J, Ziran Q, Xiaobing L (2023) The kinesin-14 family motor protein KIFC2 promotes prostate cancer progression by regulating p65. J Biol Chem 299. https:\/\/doi.org\/10.1016\/j.jbc.2023.105253.","DOI":"10.1016\/j.jbc.2023.105253"},{"key":"4040_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.23812\/19-513-l-8","volume":"34","author":"LF Xiong","year":"2020","unstructured":"Xiong LF, Lou YM, Wang L (2020) Expressions of Kif2c and Ki-67 in non-small cell lung cancer and their relationship with invasion and metastasis. J Biol Regul Homeost Agents 34:541\u2013546. https:\/\/doi.org\/10.23812\/19-513-l-8","journal-title":"J Biol Regul Homeost Agents"},{"key":"4040_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13402-018-0376-6","volume":"41","author":"M Yousefi","year":"2018","unstructured":"Yousefi M, Nosrati R, Salmaninejad A, Dehghani S, Shahryari A, Saberi A (2018) Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis. Cell Oncol (Dordr) 41:123\u2013140. https:\/\/doi.org\/10.1007\/s13402-018-0376-6","journal-title":"Cell Oncol (Dordr)"},{"key":"4040_CR36","doi-asserted-by":"publisher","unstructured":"Yu Z, Deng P, Chen Y, Liu S, Chen J, Yang Z, Chen J, Fan X, Wang P, Cai Z, Wang Y, Hu P, Lin D, Xiao R, Zou Y, Huang Y, Yu Q, Lan P, Tan J, Wu X (2021) Inhibition of the PLK1-coupled cell cycle machinery overcomes resistance to oxaliplatin in colorectal cancer. 8:e2100759. https:\/\/doi.org\/10.1002\/advs.202100759","DOI":"10.1002\/advs.202100759"},{"key":"4040_CR37","doi-asserted-by":"publisher","first-page":"1261283","DOI":"10.3389\/fendo.2023.1261283","volume":"14","author":"J Yuan","year":"2023","unstructured":"Yuan J, Yang L, Li Z, Zhang H, Wang Q, Huang J, Wang B, Mohan CD, Sethi G, Wang G (2023) The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer. Front Endocrinol 14:1261283. https:\/\/doi.org\/10.3389\/fendo.2023.1261283","journal-title":"Front Endocrinol"},{"key":"4040_CR38","doi-asserted-by":"publisher","first-page":"e113478","DOI":"10.1371\/journal.pone.0113478","volume":"9","author":"F Zhao","year":"2014","unstructured":"Zhao F, Siu MK, Jiang L, Tam KF, Ngan HY, Le XF, Wong OG, Wong ES, Gomes AR, Bella L, Khongkow P, Lam EW, Cheung AN (2014) Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance. PLoS ONE 9:e113478. https:\/\/doi.org\/10.1371\/journal.pone.0113478","journal-title":"PLoS ONE"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04040-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:37:16Z","timestamp":1758256636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04040-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04040-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were accomplished in line with to ARRIVE guidelines and ratified by the Animal Ethics and Research Committee of Yantaishan Hospital (Ethic number: 2024023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}